CA2798456A1 - Validation of point-of-care test results by assessment of expected analyte relationships - Google Patents

Validation of point-of-care test results by assessment of expected analyte relationships Download PDF

Info

Publication number
CA2798456A1
CA2798456A1 CA2798456A CA2798456A CA2798456A1 CA 2798456 A1 CA2798456 A1 CA 2798456A1 CA 2798456 A CA2798456 A CA 2798456A CA 2798456 A CA2798456 A CA 2798456A CA 2798456 A1 CA2798456 A1 CA 2798456A1
Authority
CA
Canada
Prior art keywords
analyte
potassium
clinical test
test result
total
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2798456A
Other languages
English (en)
French (fr)
Inventor
Steve C. Kazmierczak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abaxis Inc
Original Assignee
Abaxis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abaxis Inc filed Critical Abaxis Inc
Publication of CA2798456A1 publication Critical patent/CA2798456A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Primary Health Care (AREA)
  • Data Mining & Analysis (AREA)
  • Biomedical Technology (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA2798456A 2010-05-06 2011-05-06 Validation of point-of-care test results by assessment of expected analyte relationships Abandoned CA2798456A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US33215410P 2010-05-06 2010-05-06
US61/332,154 2010-05-06
US37866810P 2010-08-31 2010-08-31
US61/378,668 2010-08-31
PCT/US2011/035583 WO2011140483A2 (en) 2010-05-06 2011-05-06 Validation of point-of-care test results by assessment of expected analyte relationships

Publications (1)

Publication Number Publication Date
CA2798456A1 true CA2798456A1 (en) 2011-11-10

Family

ID=44902517

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2798456A Abandoned CA2798456A1 (en) 2010-05-06 2011-05-06 Validation of point-of-care test results by assessment of expected analyte relationships

Country Status (6)

Country Link
US (1) US20110276342A1 (https=)
EP (1) EP2567339A4 (https=)
JP (1) JP2013525819A (https=)
KR (1) KR20130105301A (https=)
CA (1) CA2798456A1 (https=)
WO (1) WO2011140483A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8645306B2 (en) 2010-07-02 2014-02-04 Idexx Laboratories, Inc. Automated calibration method and system for a diagnostic analyzer
US9151769B2 (en) * 2010-07-02 2015-10-06 Idexx Laboratories, Inc. Automated calibration method and system for a diagnostic analyzer
US11676730B2 (en) 2011-12-16 2023-06-13 Etiometry Inc. System and methods for transitioning patient care from signal based monitoring to risk based monitoring
US20130231949A1 (en) 2011-12-16 2013-09-05 Dimitar V. Baronov Systems and methods for transitioning patient care from signal-based monitoring to risk-based monitoring
EP2685264B1 (en) * 2012-07-13 2020-12-02 Idexx Laboratories, Inc. Automated calibration method and system for a diagnostic analyzer
US20140222463A1 (en) * 2013-01-31 2014-08-07 Abbott Cardiovascular Systems Inc. Enhanced monitoring
US11036779B2 (en) * 2018-04-23 2021-06-15 Verso Biosciences, Inc. Data analytics systems and methods
WO2020080491A1 (ja) * 2018-10-17 2020-04-23 株式会社 資生堂 血液中のクレアチニン量に基づく腎機能検査結果の妥当性を検定する方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK409188D0 (da) * 1988-07-21 1988-07-21 Radiometer As Fremgangsmaade til maaling af en karakteristik i et fluidum
JP2828609B2 (ja) * 1994-09-22 1998-11-25 株式会社エイアンドティー 臨床検査分析装置
US6015667A (en) * 1996-06-03 2000-01-18 The Perkin-Emer Corporation Multicomponent analysis method including the determination of a statistical confidence interval
JP2001331581A (ja) * 2000-05-22 2001-11-30 Yusuke Tsukamoto 自動診断システム、自動診断方法、治療法自動決定システム、治療法自動決定方法及び記録媒体
IL152740A0 (en) * 2000-05-31 2003-06-24 Fasttrack Systems Inc Clinical trials management system and method
WO2003019184A1 (en) * 2001-08-24 2003-03-06 Bio-Rad Laboratories, Inc. Biometric quality control process
US20060160074A1 (en) * 2001-12-27 2006-07-20 Third Wave Technologies, Inc. Pharmacogenetic DME detection assay methods and kits
US7177767B2 (en) * 2002-10-18 2007-02-13 Abaxis, Inc. Systems and methods for the detection of short and long samples
ES2334671T3 (es) * 2004-08-13 2010-03-15 Egomedical Technologies Ag Sistema de ensayo de analitos para determinar la concentracion de un analito en un fluido fisiologico o acuoso.
US8112232B2 (en) * 2007-02-02 2012-02-07 Beckman Coulter, Inc. System and method for autoverifying laboratory test results
JP5164646B2 (ja) * 2008-04-08 2013-03-21 国立大学法人高知大学 臨床検査データ解析支援装置、臨床検査データ解析支援方法及びそのプログラム
JP4872103B2 (ja) * 2009-02-05 2012-02-08 国立大学法人 大分大学 臨床検査値の管理装置、管理方法及び管理プログラム
US20110046919A1 (en) * 2009-03-02 2011-02-24 Juliesta Elaine Sylvester Method for accurate measurement of enzyme activities

Also Published As

Publication number Publication date
KR20130105301A (ko) 2013-09-25
WO2011140483A3 (en) 2012-04-05
US20110276342A1 (en) 2011-11-10
JP2013525819A (ja) 2013-06-20
EP2567339A4 (en) 2013-10-23
EP2567339A2 (en) 2013-03-13
WO2011140483A2 (en) 2011-11-10

Similar Documents

Publication Publication Date Title
CA2798456A1 (en) Validation of point-of-care test results by assessment of expected analyte relationships
Kumar et al. Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure
Ostroff et al. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer
Moodley et al. Evaluation of the CKD-EPI creatinine based glomerular filtration rate estimating equation in Black African and Indian adults in KwaZulu-Natal, South Africa
JP2013525819A5 (https=)
Li et al. Relationship of multi-biomarker disease activity score and other risk factors with radiographic progression in an observational study of patients with rheumatoid arthritis
WO2012177945A3 (en) Diagnostic methods for eosinophilic esophagitis
Peddu et al. High-resolution profiling of human cytomegalovirus cell-free DNA in human plasma highlights its exceptionally fragmented nature
EP2812693A1 (en) A multi-biomarker-based outcome risk stratification model for pediatric septic shock
CN115410713A (zh) 一种基于免疫相关基因的肝细胞癌预后风险预测模型构建
Ji et al. Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions
Mohan et al. Fibrinogen: a feasible biomarker in identifying the severity and acute exacerbation of chronic obstructive pulmonary disease
Mollee et al. Free light chain testing for the diagnosis, monitoring and prognostication of AL amyloidosis
Ferraro et al. Managing the impact of inter-method bias of prostate specific antigen assays on biopsy referral: the key to move towards precision health in prostate cancer management
Lambert et al. Plasma cystatin C is a marker of renal glomerular injury in children treated with cisplatin or ifosfamide
Cheng et al. A nomogram to predict outcomes of lung cancer patients after pneumonectomy based on 47 indicators
Chen et al. Inflammation but not dietary macronutrients insufficiency associated with the malnutrition-inflammation score in hemodialysis population
Pasqualetti et al. Heparinate but not serum tubes are susceptible to hemolysis by pneumatic tube transportation
Odsaeter et al. Establishing the 99th percentile of a novel assay for high-sensitivity troponin I in a healthy blood donor population
Gatt et al. From vitamin K antagonists to liver international normalized ratio: a historical journey and critical perspective
Shaw et al. One‐carbon metabolite levels in mid‐pregnancy and risks of conotruncal heart defects
Ferraro et al. Tracing a roadmap for vitamin B12 testing using the health technology assessment approach
Bolann Easy verification of clinical chemistry reference intervals
Raymond et al. From art to science: oligosaccharide analysis by maldi-tof mass spectrometry finally replaces 1-dimensional thin-layer chromatography
Chao et al. Towards proteome standards: the use of absolute quantitation in high-throughput biomarker discovery

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20170510